Have you or your loved ones been diagnosed with cardiogenic shock?

You may be eligible to participate in a cardiogenic shock clinical trial.

Have you or your loved ones been diagnosed with cardiogenic shock? You may be eligible to participate in a cardiogenic shock clinical trial.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Cardiogenic Shock Clinical Trial
NCT02591771 | Phase 2 | Interventional
Niguarda Hospital
Sponsored by
Niguarda Hospital

Have you or your loved ones been diagnosed with cardiogenic shock?

You may be eligible to participate in a cardiogenic shock clinical trial.

Have you or your loved ones been diagnosed with cardiogenic shock? You may be eligible to participate in a cardiogenic shock clinical trial.

Completed

Male & Female

18 Years +

This study has recruited 24 Participants

The purpose of this study is to evaluate efficacy and safety of i.v. adrenaline infusion as an early and fast haemodynamic stabilizer, associated with a tight tissue perfusion monitoring, in the context of a stepwise progression in the treatment of cardiogenic shock, including ventricular mechanical support.